Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
September 2029 50
2029-09
Study completion OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07198529
2029-09
Primary completion OCT-Guided Stent Optimization for Short-Duration Dual Antiplatelet Therapy in Stable Angina Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07198529
2029-09
Study completion Normal Saline Infusion After Intravenous Thrombolysis in Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07497542
2029-09
Primary completion Safety and Efficacy of Low-dose Anticoagulation With Argatroban and Enoxaparin on ECMO Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07499037
2029-09
2029-09
Primary completion Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage. Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07583147
2029-09
Study completion A Study of Metformin to Improve Cardiac Function After LVAD Implantation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07666698
2029-09
Primary completion Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07687485
2029-09
Study completion Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07799779
2029-09
Primary completion Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07799779
2029-09
2029-09
2029-09-03
2029-09-03
2029-09-05
2029-09-10
Primary completion ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07452991
2029-09-11
Primary completion Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07626411
2029-09-15
2029-09-15
Primary completion Safety and Performance of the SpherePVI™ Catheter to Treat Paroxysmal Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05144503
2029-09-15
Study completion Neuroprotection in Acute Cerebral Ischemia II Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07552818
2029-09-20
Study completion LAAO Versus NOAC in Patients with AF and PCI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05353140
2029-09-28
Study completion Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02915198
2029-09-28
Primary completion Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02915198
2029-09-30
Study completion The RESET System Pivotal Clinical Trial (Protocol Revision K) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04101669
2029-09-30
Study completion Pediatric Prehospital Airway Resuscitation Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06364280
2029-09-30
2029-09-30
2029-09-30
2029-09-30
2029-09-30
Primary completion Eptifibatide for Extended Window Ischemic Stroke After Thrombolysis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07347626
2029-09-30
Study completion Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07730840
2029-09-30
Primary completion Zastaprazan for the prEvention of Upper GI Bleeding in Ischemic Stroke Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07730840
2029-09-30
Primary completion PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic Responses Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07739537
2029-09-30
Study completion Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07840365
2029-09-30
October 2029 40
2029-10-01
Primary completion Assessing the Safety and Efficacy of the LAmbre™ Plus Device Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06465706
2029-10-01
Study completion Response to Exercise and Nitric Oxide in PAD Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06657976
2029-10
Study completion NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04471909
2029-10
Study completion Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04566991
2029-10
Primary completion Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04566991
2029-10
Primary completion Evaluation of the GORE® Ascending Stent Graft Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05800743
2029-10
2029-10
2029-10
2029-10
Study completion Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07164859
2029-10
Primary completion Safety and Efficacy of Very Short DAPT in Older Patients Undergoing PCI Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07164859
2029-10
Study completion Reversal to Normoglycemia by Treating Prediabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07392151
2029-10
Primary completion Reversal to Normoglycemia by Treating Prediabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07392151
2029-10
Study completion SWITCH: Apixaban vs Vitamin K in HM3 Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07471139
2029-10
Study completion A Study to Determine if BHV-1400 is Effective and Safe in Adults With IgA Nephropathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07642050
2029-10
2029-10
2029-10
2029-10
2029-10
Primary completion A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07881458
2029-10
Study completion Tolerability and Safety of Nano-Tocotrienols Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07888426
2029-10
Primary completion Tolerability and Safety of Nano-Tocotrienols Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07888426
2029-10
Study completion A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07904507
2029-10
Primary completion A Comparison of Beta-blockers and Calcium Channel Blockers in Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07904507
2029-10-09
Study completion Abatacept in Immune Checkpoint Inhibitor Myocarditis Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05335928
2029-10-15
2029-10-20
Study completion COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04606459
2029-10-26
2029-10-26
2029-10-30
Study completion Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07904624
2029-10-30
Primary completion Implementation Study on Hospital-to-home Advanced Rehabilitation Technologies (ART) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07904624
2029-10-31
2029-10-31
2029-10-31
2029-10-31
Primary completion Optimizing Reperfusion to Improve Outcomes and Neurologic Function Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06990867
2029-10-31
Study completion Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07273838
2029-10-31
Study completion Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07613970
2029-10-31
Primary completion Investigating Central Contributions to Fatigue Using Non-invasive Brain Stimulation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07613970
2029-10-31
Primary completion Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07715279
2029-10-31
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2025-10-21
Study start Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR Registry record
Expected 2025-10-21; that period ended on 2025-10-21.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07129421
2025-10-23
Study start The Safety and Efficacy of New-Generation BRS vs. DCB for De Novo Large Coronary Artery Lesions: A Prospective RCT Registry record
Expected 2025-10-23; that period ended on 2025-10-23.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07162792
2025-10-30
Primary completion Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD) Registry record
Expected 2025-10-30; that period ended on 2025-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05469659
2025-10-30
Study completion De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS Registry record
Expected 2025-10-30; that period ended on 2025-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05903976
2025-10-30
Study completion Normobaric Hyperoxia Combined With Intravenous Thrombolysis for Acute Ischemic Stroke:Longterm Outcome (OPENS-3L) Registry record
Expected 2025-10-30; that period ended on 2025-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05965193
2025-10-30
Primary completion Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE Registry record
Expected 2025-10-30; that period ended on 2025-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06189950
2025-10-30
Study start Interleukin-6 Receptor Inhibition for Symptomatic Intracranial Atherosclerosis Registry record
Expected 2025-10-30; that period ended on 2025-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06447701
2025-10-30
Study completion The Androtriol Injection for the Treatment of Acute Ischemic Stroke Registry record
Expected 2025-10-30; that period ended on 2025-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06679322
2025-10-30
Study completion Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes Registry record
Expected 2025-10-30; that period ended on 2025-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06712615
2025-10-30
Primary completion Phase II Study of PG-102(MG12) Compared With Placebo in Obesity and Type 2 Diabetes Registry record
Expected 2025-10-30; that period ended on 2025-10-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06712615
2025-10-30
2025-10-31
Study completion Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02004509
2025-10-31
Primary completion Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02004509
2025-10
Study completion The Recovery in Stroke Using PAP Study Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04130503
2025-10
Primary completion The Recovery in Stroke Using PAP Study Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04130503
2025-10-31
Primary completion Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04263922
2025-10
Primary completion NEXUS Aortic Arch Clinical Study to Evaluate Safety and Effectiveness Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04471909
2025-10
Study completion Image Supported Lead Placement in CRT Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05053568
2025-10
Primary completion The ELG Analysis of Glucose a Correlational to Blood Glucose Assay Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05055804
2025-10-31
Primary completion Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF) Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05172765
2025-10-31
Primary completion MAGNAM Trial, Magnesium Versus Amiodarone in Atrial Fibrillation in Critical Care Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05287191
2025-10
Study completion EMPAGUM: Effects of Empagliflozin on Gut Microbiota in Heart Failure With a Preserved Ejection Fraction Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05584319
2025-10
Study completion Empagliflozin on the Function of Left Atrium in Heart Failure With Mildly Reduced or Preserved Ejection Fraction Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05600387
2025-10-31
Study completion Beneficial Effects of Vitamin D Combined With Oral Iron Supplementation in Patients With Chronic Heart Failure and Iron Deficiency Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05702970
2025-10-31
Primary completion Improving Stroke Care in North-Norway Through Artificial Intelligence Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05903898
2025-10-31
Primary completion A Prospective Multicenter Pivotal Study to Evaluate Safety and Effectiveness of Venus-Neo Surgical Aortic Valve Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05941455
2025-10-31
Study completion Assessment of Efficacy and Safety of Amicomed®, for the Management of Essential Hypertension Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06091176
2025-10
Study completion A Trial to Investigate the Efficacy and Safety of NW Low-Glu® in Patients With Type II Diabetes Mellitus Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06140485
2025-10
Primary completion Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4) Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06319846
2025-10-31
Primary completion Real World Evaluation of Lifelight®: A Contactless Vital Signs Monitor for Self-monitoring Blood Pressure and Its Comparison to Standard of Care Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06325384
2025-10-31
Primary completion Bioabsorbable/Nufairy Coil Application Trial in China Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06466564
2025-10
Primary completion Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06479343
2025-10
Primary completion A Trial Investigating the Efficacy and Safety of Insulin Degludec/Liraglutide Injection in Subjects With Type 2 Diabetes Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06559722
2025-10
Primary completion Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI) Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06754839
2025-10-31
Study completion CAP-TEER: CerebrAl Protection During Transcatheter Edge-to-edge Repair Registry record
Expected 2025-10-31; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06814210
2025-10
Study start Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression Registry record
Expected 2025-10; that period ended on 2025-10-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06866236
2025-10
2025-10
2025-11-01
Study completion The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy Registry record
Expected 2025-11-01; that period ended on 2025-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05961202
2025-11-01
Primary completion Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders Registry record
Expected 2025-11-01; that period ended on 2025-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06980753
2025-11-01
Study start CGM Use in Non-insulin Patients With DM2 Registry record
Expected 2025-11-01; that period ended on 2025-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07128342
2025-11-01
Study start Tenecteplase vs Medical Management in 4.5-24h LVO no Access to EVT Registry record
Expected 2025-11-01; that period ended on 2025-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07168278
2025-11-01
Study start Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease Registry record
Expected 2025-11-01; that period ended on 2025-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07180745
2025-11-01
Study start RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction Registry record
Expected 2025-11-01; that period ended on 2025-11-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07203521
2025-11-05
Primary completion Treatment of PAF With the Synaptic System Registry record
Expected 2025-11-05; that period ended on 2025-11-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05905835
2025-11-05
Study start DCB vs. DES in Young STEMI Patients: The DCB-STEMI Trial Registry record
Expected 2025-11-05; that period ended on 2025-11-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07229248
2025-11-10
Primary completion Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention Registry record
Expected 2025-11-10; that period ended on 2025-11-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07243080
2025-11-14
Primary completion Phimume® Percutaneous Left Ventricular Assist System Study Registry record
Expected 2025-11-14; that period ended on 2025-11-14.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06639321
2025-11-15
Study completion Comparative Efficacy of Rivaroxaban and Enoxaparin in Post-Laparotomy DVT Prevention Registry record
Expected 2025-11-15; that period ended on 2025-11-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07243080
2025-11-22
Study completion Mobile Application for Self-Management of Type 2 Diabetes Mellitus Registry record
Expected 2025-11-22; that period ended on 2025-11-22.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06176703
2025-11-24
Primary completion VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication. Registry record
Expected 2025-11-24; that period ended on 2025-11-24.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03686306
2025-11-24
2025-11-30
Study completion Non-elastic Compression Garment Therapy Versus Control for Deep Vein Thrombosis Registry record
Expected 2025-11-30; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03368313
2025-11
Study completion Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04838392
2025-11
Study completion The ELG Analysis of Glucose a Correlational to Blood Glucose Assay Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05055804
2025-11
Study completion Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05487261
2025-11-30
2025-11
Study completion Effect of Prolonged Use of Dronedarone on Recurrence in Patients With Non-paroxysmal Atrial Fibrillation After Radiofrequency Ablation Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05655468
2025-11-30
Primary completion Vagal Nerve Stimulation for the Treatment of Persistent AF Registry record
Expected 2025-11-30; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05833373
2025-11
Primary completion Innovative Approaches for Personalised Cardiovascular Prevention Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05883878
2025-11
Primary completion Clinical Study on the Noninvasive Lung Fluid Monitoring System in Guiding the Treatment of Heart Failure Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06102031
2025-11
Study completion Natriuresis-Guided Diuretic Therapy in Patients With Acute Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06203236
2025-11-30
Primary completion Ticagrelor Versus Cilostazol in Ischemic Stroke Registry record
Expected 2025-11-30; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06561867
2025-11-30
Primary completion Vaccination Against Influenza Pre-discharge in Heart Failure Registry record
Expected 2025-11-30; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06725927
2025-11-30
Study completion Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction Registry record
Expected 2025-11-30; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06742567
2025-11-30
Primary completion Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction Registry record
Expected 2025-11-30; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06742567
2025-11
Primary completion WeArable teChnology daTa driVen digitAl healTh cOachINg (ACTIVATION)- A Mixed-methods Study Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06752772
2025-11-30
Primary completion Aleeto in Acute ISchemic Stroke:A RandomISed Controlled Clinical Trial Registry record
Expected 2025-11-30; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06759753
2025-11-30
Study start Ganagliflozin on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease Registry record
Expected 2025-11-30; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07116928
2025-11
2025-11
Study start Sacubitril/Allisartan for Hypertensive Patients With Overweight or Obesity Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07241338
2025-11
Study start Evaluating Functional Outcomes of 3D-Printed Splints in Post-Stroke Upper Limb Recovery Registry record
Expected 2025-11; that period ended on 2025-11-30.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07243314
2025-12-01
Study completion HELIOS China Registry: Evaluation of the HELIOS Stent in a Real-World Patient Population Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03916432
2025-12-01
Study completion Short Arm Human Centrifuge Therapeutic Training and Rehabilitation (GRACER1) Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04369976
2025-12-01
Study completion TROPHY PAH Pivotal Study - TReatment of Pulmonary HYpertension for PAH Pivotal Study Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04570228
2025-12-01
Study completion A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05302050
2025-12-01
Primary completion A Cognitive Behavioral Digital Therapeutic InterventiON for Glycemic Control in Type 2 Diabetes Mellitus Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05302050
2025-12-01
Study completion Left Ventricular Unloading to Improve Outcome in Cardiogenic Shock Patients on VA-ECMO Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05577195
2025-12-01
Primary completion High-Dose Atorvastatin for Vascular Wall Protection in Thrombectomy Patients Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05912686
2025-12-01
Study completion Evaluation of the Safety and Efficacy of SGLT2 Inhibitors in Pre-diabetic Patients Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05914857
2025-12-01
Study completion taVNS Paired With Motor Training for Upper-extremity Rehabilitation in Stroke Patients Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05943431
2025-12-01
Study completion Effect of Spironolactone in the Prevention of Anthracycline-induced Cardiotoxicity (SPIROTOX) Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06005259
2025-12-01
Primary completion Pulsed-field Ablation for Patients With Asymptomatic Non-paroxysmal Atrial Fibrillation Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06166524
2025-12-01
Primary completion Optimal Medical Treatment of Difficult-to-treat Hypertension Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06275763
2025-12-01
Study completion Effects of First-Line Oral Hypoglycemics in Bone Markers of Treatment Naïve Saudi Adults With Type 2 Diabetes Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06439758
2025-12-01
Primary completion Ticagrelore Alone Post PCI Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06509893
2025-12-01
Primary completion Emergency Stroke Unit for Acute Cerebrovascular Events ( ESU-ACE-D ) Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06522282
2025-12-01
Primary completion PREVENTION OF WORSENING RENAL FUNCTION OF INTRAVENUS ALBUMIN IN HEART FAILURE PATIENTS Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06630923
2025-12-01
Study completion Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06980753
2025-12-01
Study start Intravenous Tirofiban After Delayed Thrombolysis in Stroke Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07111806
2025-12-01
Study start Development and Validation of a Comprehensive Management Service Package for Older Adults With Multimorbidity Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07151430
2025-12-01
Study start Butylphthalide for Long-term Efficacy in Minor Stroke Study Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07230587
2025-12-01
2025-12-01
Study start Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT) Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07252544
2025-12-01
Study start Acetyl-leucine in Post-stroke Ataxia Registry record
Expected 2025-12-01; that period ended on 2025-12-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07275749
2025-12-05
Study completion Treatment of PAF With the Synaptic System Registry record
Expected 2025-12-05; that period ended on 2025-12-05.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05905835
2025-12-15
Primary completion Combinating Fingolimod With Alteplase Bridging With Thrombectomy in Acute Ischemic Stroke Registry record
Expected 2025-12-15; that period ended on 2025-12-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04675762
2025-12-15
Study completion Olive Leaf Extracts in the Control of Diabet Registry record
Expected 2025-12-15; that period ended on 2025-12-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05605704
2025-12-15
Study start A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. Registry record
Expected 2025-12-15; that period ended on 2025-12-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06731075
2025-12-15
Primary completion Evaluate the Efficacy and Safety of SPC1001 Low in Patients With Essential Hypertension Registry record
Expected 2025-12-15; that period ended on 2025-12-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07064525